On Tuesday, January 22 2008 Merck/Schering-Plough announced the pulling of all TV advertisements for the drugs Zetia and Vytorin. Zetia alone is a Merck/Scherin anti-cholesterol drug and Vytorin is a drug that contains both Zetia and Zocor(simvastation).

At least one of the ads boasted that Zetia was far greater than less expensive statin drugs for lowering cholesterol. These ads stated this even though Merck/Schering’s ENHANCE testing data proved that neither Zetia or Vytorin performed better than and statin alone.

The ads are pulled as mounting consumer reports of severe and potentially life threatening side effects appear to be growing related to rhabdomyolysis, a rare a potentially fatal disease involving degeneration and destruction of skeletal muscle, as well as serious liver related injuries and damage, thrombocytopenia, hepatitis and pancreatitis.

Please visit http://www.resource4thepeople.com for details.